Century Therapeutics, Inc.

NasdaqGS:IPSC Stock Report

Market Cap: US$50.0m

Century Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGS:IPSC Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
10 Mar 25SellUS$763Douglas CarrIndividual1,240US$0.61
10 Mar 25SellUS$1,451Adrienne FaridIndividual2,359US$0.61
10 Mar 25SellUS$1,451Gregory RussottiIndividual2,360US$0.61
10 Mar 25SellUS$1,375Brent PfeiffenbergerIndividual2,235US$0.61
18 Feb 25SellUS$27,179Brent PfeiffenbergerIndividual34,712US$0.78
03 Feb 25SellUS$274Douglas CarrIndividual351US$0.78
03 Feb 25SellUS$822Adrienne FaridIndividual1,054US$0.78
04 Nov 24SellUS$347Douglas CarrIndividual283US$1.23
04 Nov 24SellUS$1,267Adrienne FaridIndividual1,033US$1.23
12 Sep 24BuyUS$7,657Daphne QuimiIndividual5,000US$1.53
05 Aug 24SellUS$528Douglas CarrIndividual289US$1.83
05 Aug 24SellUS$1,960Adrienne FaridIndividual1,073US$1.83
03 May 24SellUS$2,836Adrienne FaridIndividual913US$3.11
03 May 24SellUS$798Douglas CarrIndividual257US$3.11

Insider Trading Volume

Insider Buying: IPSC insiders have only sold shares in the past 3 months.

Ownership Breakdown

What is the ownership structure of IPSC?
Owner TypeNumber of SharesOwnership Percentage
Private Companies00%
Individual Insiders3,834,5394.51%
General Public9,643,69611.3%
Public Companies19,631,04523.1%
VC/PE Firms22,766,97626.8%
Institutions29,152,78634.3%

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 31.2%.

Top Shareholders

Top 25 shareholders own 83.28% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.9%
Bayer Aktiengesellschaft
12,675,838US$7.5m0%no data
14.3%
Versant Venture Management, LLC
12,166,109US$7.2m0%3.35%
8.18%
FUJIFILM Holdings Corporation
6,955,207US$4.1m0%no data
6.36%
Bain Capital Life Sciences Investors, LLC
5,410,361US$3.2m0%0.44%
6.1%
Casdin Capital, LLC
5,190,506US$3.1m61.6%0.22%
4.65%
VR Adviser, LLC
3,957,186US$2.3m-26.6%0.2%
3.73%
Boxer Capital Management, LLC
3,174,603US$1.9m0%0.17%
3.57%
BlackRock, Inc.
3,037,248US$1.8m1.58%no data
2.98%
FMR LLC
2,533,874US$1.5m0.49%no data
2.8%
The Vanguard Group, Inc.
2,381,707US$1.4m-3.78%no data
2%
Dafna Capital Management, LLC
1,704,232US$1.0m0%0.28%
1.89%
Millennium Management LLC
1,607,174US$945.2k1,040%no data
1.55%
Osvaldo Flores
1,321,719US$777.3k0%no data
1.43%
Syncona Investment Management Limited
1,213,056US$713.4k0%1.03%
1.41%
Renaissance Technologies LLC
1,202,885US$707.4k146%no data
1.17%
Geode Capital Management, LLC
991,595US$583.2k2.42%no data
1.06%
Tang Capital Management, LLC
900,000US$529.3k0%0.03%
1%
State Street Global Advisors, Inc.
852,791US$501.5k1.9%no data
0.94%
Baker Bros. Advisors LP
797,460US$469.0k0%no data
0.63%
Hyam Levitsky
536,544US$315.5k0%no data
0.61%
Citadel Advisors LLC
520,228US$305.9k2,710%no data
0.58%
Joseph Jimenez
494,345US$290.7k0%no data
0.54%
Superstring Capital Management LP
462,963US$272.3k0%0.26%
0.44%
Brent Pfeiffenberger
370,271US$217.8k12.4%no data
0.42%
Charles Schwab Investment Management, Inc.
357,805US$210.4k0.7%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/19 05:44
End of Day Share Price 2025/03/19 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Century Therapeutics, Inc. is covered by 12 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Geoffrey MeachamBofA Global Research
Charlie YangBofA Global Research
William MaughanCanaccord Genuity